-
Je něco špatně v tomto záznamu ?
Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology
E. Holaskova, P. Galuszka, I. Frebort, MT. Oz,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- biotechnologie metody MeSH
- exprese genu * MeSH
- kationické antimikrobiální peptidy biosyntéza farmakologie MeSH
- rostliny metabolismus MeSH
- zemědělství metody MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Antimicrobial peptides (AMPs) are vital components of the innate immune system of nearly all living organisms. They generally act in the first line of defense against various pathogenic bacteria, parasites, enveloped viruses and fungi. These low molecular mass peptides are considered prospective therapeutic agents due to their broad-spectrum rapid activity, low cytotoxicity to mammalian cells and unique mode of action which hinders emergence of pathogen resistance. In addition to medical use, AMPs can also be employed for development of innovative approaches for plant protection in agriculture. Conferred disease resistance by AMPs might help us surmount losses in yield, quality and safety of agricultural products due to plant pathogens. Heterologous expression in plant-based systems, also called plant molecular farming, offers cost-effective large-scale production which is regarded as one of the most important factors for clinical or agricultural use of AMPs. This review presents various types of AMPs as well as plant-based platforms ranging from cell suspensions to whole plants employed for peptide production. Although AMP production in plants holds great promises for medicine and agriculture, specific technical limitations regarding product yield, function and stability still remain. Additionally, establishment of particular stable expression systems employing plants or plant tissues generally requires extended time scale for platform development compared to certain other heterologous systems. Therefore, fast and promising tools for evaluation of plant-based expression strategies and assessment of function and stability of the heterologously produced AMPs are critical for molecular farming and plant protection.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020931
- 003
- CZ-PrNML
- 005
- 20160722121439.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biotechadv.2015.03.007 $2 doi
- 024 7_
- $a 10.1016/j.biotechadv.2015.03.007 $2 doi
- 035 __
- $a (PubMed)25784148
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Holaskova, Edita $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: editaa@seznam.cz.
- 245 10
- $a Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology / $c E. Holaskova, P. Galuszka, I. Frebort, MT. Oz,
- 520 9_
- $a Antimicrobial peptides (AMPs) are vital components of the innate immune system of nearly all living organisms. They generally act in the first line of defense against various pathogenic bacteria, parasites, enveloped viruses and fungi. These low molecular mass peptides are considered prospective therapeutic agents due to their broad-spectrum rapid activity, low cytotoxicity to mammalian cells and unique mode of action which hinders emergence of pathogen resistance. In addition to medical use, AMPs can also be employed for development of innovative approaches for plant protection in agriculture. Conferred disease resistance by AMPs might help us surmount losses in yield, quality and safety of agricultural products due to plant pathogens. Heterologous expression in plant-based systems, also called plant molecular farming, offers cost-effective large-scale production which is regarded as one of the most important factors for clinical or agricultural use of AMPs. This review presents various types of AMPs as well as plant-based platforms ranging from cell suspensions to whole plants employed for peptide production. Although AMP production in plants holds great promises for medicine and agriculture, specific technical limitations regarding product yield, function and stability still remain. Additionally, establishment of particular stable expression systems employing plants or plant tissues generally requires extended time scale for platform development compared to certain other heterologous systems. Therefore, fast and promising tools for evaluation of plant-based expression strategies and assessment of function and stability of the heterologously produced AMPs are critical for molecular farming and plant protection.
- 650 _2
- $a zemědělství $x metody $7 D000383
- 650 _2
- $a kationické antimikrobiální peptidy $x biosyntéza $x farmakologie $7 D023181
- 650 _2
- $a biotechnologie $x metody $7 D001709
- 650 12
- $a exprese genu $7 D015870
- 650 _2
- $a rostliny $x metabolismus $7 D010944
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Galuszka, Petr $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: petr.galuszka@upol.cz.
- 700 1_
- $a Frebort, Ivo $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: ivo.frebort@upol.cz.
- 700 1_
- $a Oz, M Tufan $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: tufan.oz@ufl.edu.
- 773 0_
- $w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 33, č. 6 Pt 2 (2015), s. 1005-23
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25784148 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160722121653 $b ABA008
- 999 __
- $a ok $b bmc $g 1155601 $s 945459
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 33 $c 6 Pt 2 $d 1005-23 $e 20150314 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
- LZP __
- $a Pubmed-20160722